COMP <GO>
BKD vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Brookdale Senior Living Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BKD 1
— MRK 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $10.27 (+2.91%) • MKT CAP: $2.45B
balance-sheet
0.20
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.20% | 74.80% | -48.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.30% | 20.70% | -20.40 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.6x | 15.3x | +19.30 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 3.42% | -2.75 | MRK | /fcf-yield <GO> |
| Operating Margin | 0.40% | 34.30% | -33.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | -8.20% | 28.10% | -36.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 1.30% | +0.90 | BKD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 51.7 | -5.70 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.45B | $361.02B | -$358.57B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKD REV | MRK REV | BKD GROSS % | MRK GROSS % | BKD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.19B | $65.01B | 26.2% | 74.8% | $16.5M | $12.36B |
| FY 2024 | $3.13B | $64.17B | 25.6% | 76.3% | -$35.1M | $18.10B |
| FY 2023 | $3.02B | $60.12B | — | — | $162.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKD // BETA —
MRK // BETA 0.92